- 122341-40-613-36-Neuropeptide Y(human) (9CI)
- 122341-56-4Phenol,3-(4-methoxyspiro[1,2-dioxetane-3,2'-tricyclo[3.3.1.13,7]decan]-4-yl)-,1-(dihydrogen phosphate)
- 12234-51-4C.I.Acid Black 62 (8CI,9CI)
- 12234-64-9C.I. Acid Blue 185
- 12234-73-0C.I. Acid Brown 19
- 12234-74-1C.I. Acid Brown 290(8CI,9CI)
- 122-34-91,3,5-Triazine-2,4-diamine,6-chloro-N2,N4-diethyl-
- 122349-66-02-Naphthalenecarboxaldehyde,5-bromo-
- 12234-98-9C.I. Acid Red 122
- 12234-99-0C.I. Acid Red 131
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Temoporfin |
EINECS | 624-374-5 |
| CAS No. | 122341-38-2 | Density | 1.386 g/cm3 |
| PSA | 137.22000 | LogP | 5.91260 |
| Solubility | N/A | Melting Point |
>250 °C |
| Formula | C44H32N4O4 | Boiling Point | N/A |
| Molecular Weight | 680.762 | Flash Point | N/A |
| Transport Information | N/A | Appearance | N/A |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
3,3',3'',3'''-(7,8-Dihydroporphyrin-5,10,15,20-tetrayl)tetraphenol;5,10,15,20-Tetra(m-hydroxyphenyl)chlorin;5,10,15,20-Tetrakis(m-hydroxyphenyl)chlorin;8-Dihydroporphyrin-5;EF 9;Foscan;Fosgel;Foslip;Fospeg;mTHPC; |
Article Data | 3 |
Temoporfin Specification
The IUPAC name of Temoporfin is 3-[10,15,20-tris(3-hydroxyphenyl)-2,3,22,24-tetrahydroporphyrin-5-yl]phenol . With the CAS registry number 122341-38-2, it is also named as 3,3',3'',3'''-(7,8-Dihydroporphyrin-5,10,15,20-tetrayl)tetraphenol ; 3,3',3',3'''-(7,8-Dihydroporphyrin-5,10,15,20-tetrayl)tetraphenol ; EF9 ; Foscan ; Phenol, 3,3',3',3'''-(7,8-dihydro-21H,23H-porphine-5,10,15,20-tetrayl)tetrakis- ; UNII-FU21S769PF ; meso-Tetrahydroxyphenylchlorin . The product's classification code are antineoplastic, antineoplastic agents, dermatologic agents, photosensitizing agents and radiation-sensitizing agents.
The brand name of temoporfin is Foscan which marketed in the European Union. It is a photosensitizer used in chemotherapy for the treatment of squamous cell carcinoma of the head and neck. In a murine tumor model, the distribution of temoporfin can be used as a new photosensitizer for the photodynamic therapy of cancer.
What can I do for you?
Get Best Price
